Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
07/2003
07/23/2003CN1431999A Indole derivatives with vascular damagine activity
07/23/2003CN1431998A Growth hormone secretagogues
07/23/2003CN1431941A 挤压模 Extrusion die
07/23/2003CN1431908A Kits and methods for optimizing efficacy of chondroprotective compsns.
07/23/2003CN1431904A Protease inhitors
07/23/2003CN1431898A Methods of use of penicillamines for treatment of conditions resulting from DNA damage
07/23/2003CN1431221A Total saponin of polygara aureocauda dunn and madication combination as well as its preparing method
07/23/2003CN1431215A Method for preparing glucoside in resveratrol of medicine to nourish liver and lowering fat
07/23/2003CN1431200A Compound of phycocyania of blue-green algae, its preparing method and usage
07/23/2003CN1431185A Method for preparing extractive of unsaturated fatty acid possessing function of lowering fat from camellia seeds
07/23/2003CN1431016A Compositions of health care food for regulating blood sugar and fat as well as its preparing method
07/23/2003CN1431005A Product containing extractive of balsam pear and pumpkin possessing functions of reducing blood sugar and fat
07/23/2003CN1431002A Health care combination of propolis for reducing blood sugar and fat as well as method for mfg. its capsule
07/23/2003CN1431001A Medicine for curing diabetic nephropathy and its preparing method
07/23/2003CN1430993A Spartina capsules for reducing blood fat and its prodn. technique
07/23/2003CN1430990A Detoxification tea of white bamboo
07/23/2003CN1430982A Capsule of astragalus and honey as well as its preparing technique
07/23/2003CN1430964A Extractive preparation containing total alkali of mulberry leaves and its preparing method
07/23/2003CN1430959A Compsn. contg. 5-[4-[2-(N-methyl-N-2-pyridyl) amino-) oxethyl] beazyl] thiazolidine-2,4-tetraethyldiaminobenzophenone
07/23/2003CN1430957A Application of alpha benzyl, beta benzyl and gamma butyrolactone for preparing medicine of lowering blood sugar
07/23/2003CN1115159C Red sage contg. medicine compsn. and its prepn. process and application
07/23/2003CN1115156C Antisenescence Chinese medicine
07/23/2003CN1115151C Mixture of vasodilating agents and medical diluet or carrier in prepn. of medicine for treating liver disease
07/22/2003US6596867 Bone disorders
07/22/2003US6596791 Polymer complexes of glucuronoglucanes
07/22/2003US6596772 Relates to trifluoromethyl sulfonyl and trifluoromethyl sulfonamido compounds and the physiologically acceptable salts and the prodrugs thereof. These compounds are expected to modulate the activity of protein tyrosine enzymes which are
07/22/2003US6596769 20-Hete antagonists and agonists
07/22/2003US6596766 Method for relieving arachidonic acid deficient conditions and maintaining a good fatty acid balance in vivo in mammals excluding humans, comprising the process of administering 4, 7, 10, 13, 16-docosapentaenoic acid (DPA)-containing material
07/22/2003US6596758 Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process
07/22/2003US6596751 α-substituted carboxylic acid derivatives
07/22/2003US6596750 Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
07/22/2003US6596749 Neuropeptide y receptor ligand
07/22/2003US6596745 Method for treating fibrotic diseases with azolium chroman compounds
07/22/2003US6596742 Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, their preparation and their use in medicaments
07/22/2003US6596738 Inhibiting activity to adenosine deaminase (hereinafter described as ADA) An adenosine deaminase inhibiting agent comprising a compound of the formula (I):
07/22/2003US6596732 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same
07/22/2003US6596730 Phenyl urea and phenyl thiourea derivatives
07/22/2003US6596728 A pharmaceutical composition, comprising at least one compound or salt thereof as claimed in claim 1 and a polypeptides with excipients
07/22/2003US6596721 (6S)- or 10 (6R,S)- tetrahydrofolic acid is crystallized in a polar medium with pH of 3.5 or greater and have a purity 98%
07/22/2003US6596701 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
07/22/2003US6596696 Alpha-amylase inhibitor for the prophylaxis and treatment of hyperglycemia
07/22/2003US6596687 Cell adhesion inhibitors
07/22/2003US6596518 Culture product; lipase inhibitor
07/22/2003US6596515 Insulin gene amplified from human genomic DNA by use of a pair of insulin primers and a K14 promoter gene amplified by use of a pair of K14 primers inserted together into pUChsneo
07/22/2003US6596317 Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it
07/22/2003US6596261 Maximizing drug delivery to lungs
07/22/2003CA2294422C Tartrate salt of a substituted dipeptide
07/21/2003CA2416791A1 A receptor-ligand pairing for immune response
07/21/2003CA2368656A1 Receptor-ligand pairing for anti-inflammatory response
07/17/2003WO2003058203A2 Extended glucagon-like peptide-1 analogs
07/17/2003WO2003057878A1 INDUCTION OF THE FORMATION OF INSULIN-PRODUCING CELLS VIA GENE TRANSFER OF PANCREATIC β-CELL-ASSOCIATED TRANSCRIPTIONAL FACTOR
07/17/2003WO2003057862A2 Transdifferentiation of pancreatic acinar cells
07/17/2003WO2003057856A2 Dominant negative proteins and methods thereof
07/17/2003WO2003057854A2 Novel proteins and nucleic acids encoding same
07/17/2003WO2003057725A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
07/17/2003WO2003057722A2 Cyclic tetrapeptide compound and use thereof
07/17/2003WO2003057707A1 2-o-( -d-glucopyranosyl)ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it
07/17/2003WO2003057699A1 Dibenzodiazepine derivates, their preparation and use
07/17/2003WO2003057698A2 Spiroazacyclic compounds as monoamine receptor modulators
07/17/2003WO2003057696A1 Deazapurines and uses thereof
07/17/2003WO2003057691A1 Process and intermediates for pyridazinone antidiabetic agents
07/17/2003WO2003057684A1 Process for the preparation of simvastatin
07/17/2003WO2003057674A1 4-sulfide / sulfoxide / sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor
07/17/2003WO2003057673A1 1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor
07/17/2003WO2003057671A1 Biaryl compound and use thereof
07/17/2003WO2003057666A2 Inhibitors of dipeptidyl peptidase iv
07/17/2003WO2003057650A2 Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate
07/17/2003WO2003057380A2 Compositions including ammonia oxidizing bacteria and methods of using same
07/17/2003WO2003057256A1 Hard capsules
07/17/2003WO2003057255A1 Drugs against obeisty and drugs against fatty liver
07/17/2003WO2003057252A1 Human mast cell-expressed membrane proteins
07/17/2003WO2003057245A1 Compositions for improving lipid metabolism
07/17/2003WO2003057244A2 Use of amylin agonists to modulate triglycerides
07/17/2003WO2003057237A1 Use of interleukin-6 for treatment of obesity
07/17/2003WO2003057236A1 Body weight gain inhibitor
07/17/2003WO2003057235A2 Modification of feeding behavior
07/17/2003WO2003057230A1 Composition used for combating cholesterol and improving digestion
07/17/2003WO2003057225A2 Phosphate transport inhibitors
07/17/2003WO2003057224A1 Apoptosis inductor
07/17/2003WO2003057220A1 Cyclic urea derivatives with 5-ht2c receptor activity
07/17/2003WO2003057219A1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder
07/17/2003WO2003057216A1 Pharmaceutical composition comprising a glitazone and a 4-oxobutanoic acid, and the use thereof for treating diabetes
07/17/2003WO2003057205A2 Combination of mtp inhibitors or apob secretion inhibitors with fibrates for use as drugs
07/17/2003WO2003057200A2 Compositions comprising inhibitors of dpp-iv and nep enzymes for the treatment of diabetes
07/17/2003WO2003057196A1 Drug mixture with enhanced dissolution rate
07/17/2003WO2003057195A1 Pravastatin pharmaceutical formulations and methods of their use
07/17/2003WO2003057170A2 Oral insulin therapy
07/17/2003WO2003057166A2 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin
07/17/2003WO2003057148A2 Use of biomolecular targets in the treatment and visualization of tumors
07/17/2003WO2003057147A2 Useful aroyl pyrrole heteroaryl methanones and methanols
07/17/2003WO2003057144A2 Change inhibitors of dipeptidyl peptidase iv
07/17/2003WO2003057134A2 Specific binding agents of human angiopoietin-2
07/17/2003WO2003008410A3 Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression
07/17/2003WO2003000896A3 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE
07/17/2003WO2002059286A3 Adenylate cyclases
07/17/2003WO2002057450A3 Proteins and nucleic acids encoding same
07/17/2003WO2002055496A8 Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
07/17/2003WO2002055495A8 Aryl piperidine derivatives as inducers of ldl-receptor expression
07/17/2003WO2002031134A3 Novel serine protease genes related to dppiv
07/17/2003WO2002022805A3 Modulation of il-2- and il-15-mediated t cell responses
1 ... 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 ... 1298